Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide

NCT02502864 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Breast Cancer Female

Interventions

DRUG: Standard of Care: Docetaxel
DRUG: Standard of Care: Cyclophosphamide
OTHER: Function Assessment of Cancer Therapy (FACT) Surveys

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]